pneumococcal conjugate – Talk Bio

Actionable Insights Powered by AI

Sanofi and SK Bioscience Enhance Partnership for Next-Generation Pneumococcal Conjugate Vaccines

4 months ago talkbio0Tagged Adult, Bioscience, DKK1 gene, next-generation, PCV21, PCVs, Pediatric brand name, Phase III Testing, pneumococcal conjugate, sanofi, Vaccines

Sanofi, SK Bioscience, Pneumococcal Conjugate Vaccines (PCVs), Next-Generation Vaccines, Pediatric and Adult Populations, Phase III Testing, PCV21

Vaxcyte Announces Positive Phase 1/2 Results for VAX-31, Advances to Phase 3

8 months ago talkbio0Tagged Bacterial Infections, development aspects, Phase 3 program, pneumococcal conjugate, Vaccines, VAX-31, Vaxcyte

Vaxcyte, VAX-31, pneumococcal conjugate vaccine, Phase 1/2 study, Phase 3 program, vaccine development, bacterial diseases